3 Top Canadian AI Stocks With Revenue Growth Up To 37%

Global government bond yields are nearing 4%, which raises borrowing costs and makes cheap capital harder to find. That puts a spotlight on businesses that can use artificial intelligence to cut waste in healthcare rather than rely on easy debt. Canadian AI-focused healthcare stocks tap into this shift by aiming to improve diagnostics and hospital efficiency. This article highlights three from our screener that many investors are watching closely.

The three stocks below are just a sample from this theme, and the full screen surfaced 6 more businesses using AI in healthcare with equally compelling stories that are not covered here. To go straight to the full list and identify which AI healthcare stocks best fit your own criteria, analyze the Transformative Artificial intelligence (AI) Healthcare Stocks screener.

Profound Medical (TSX:PRN)

Overview: Profound Medical develops AI powered, MRI guided, incision free systems like TULSA-PRO and Sonalleve to precisely ablate diseased tissue in prostate and other conditions.

Operations: Profound Medical generates about $19 million from its Medical Technology segment, with roughly $12 million in the US, $6 million in Canada and under $1 million in Germany.

Market Cap: $301 million

Profound Medical focuses on AI driven, MRI guided procedures, using robotic control and real time feedback to target prostate and other tumors with the goal of greater precision compared with traditional surgery. Recent software updates to the TULSA-PRO platform and new leadership from experienced imaging executives highlight a business model where AI is integrated into each procedure. One remaining operational pressure could still influence how quickly margins align with the pace of clinical adoption.

That margin question is exactly what the Profound Medical financial health report could help you unpack so you can see how Profound Medical’s balance sheet lines up with its ambitions.

Healwell AI (TSX:AIDX)

Overview: Healwell AI develops healthcare AI engines and clinical decision tools that analyse medical data to help clinicians spot and manage rare and chronic diseases more accurately.

Operations: Healwell AI generates about $119 million from Healthcare Software and $10 million from AI and Data Sciences, mostly across Australia and New Zealand.

Market Cap: $238 million

Healwell AI sits at the intersection of AI driven diagnostics and clinical workflows, using its DARWEN platform to plug decision support directly into electronic records and day to day patient care.

"The vast and growing pool of digitized healthcare data, strengthened by ongoing adoption of telemedicine and electronic health records worldwide, will supercharge the training and effectiveness of Healwell's AI models. This could enable the launch of next-generation clinical decision tools with significant pricing power and expanded SaaS revenue streams."

How sensitive is Healwell AI’s earnings power to a single assumption about the pace at which health systems adopt this tooling, whether more slowly or more quickly than expected?

That adoption swing is exactly what the full narrative for Healwell AI unpacks, mapping how different rollout speeds could accelerate, stall, or mask where Healwell AI’s long term opportunity really sits.

Perimeter Medical Imaging AI (TSXV:PINK)

Overview: Perimeter Medical Imaging AI develops OCT imaging systems and Claire OCT with ImgAssist AI to support real-time cancer surgery margin decisions.

Operations: Perimeter Medical Imaging AI generates about $2 million from Medical Imaging Systems, entirely from customers in Canada.

Market Cap: $44 million

Perimeter Medical Imaging AI gives surgeons AI guided, intraoperative views of breast tissue margins, while still reporting only modest Canadian imaging sales and a loss making profile. The first commercial rollout of Claire OCT with ImgAssist at Intermountain Health illustrates a potential shift in surgeon adoption and its implications for the company’s path to scale.

That early US rollout could be the start of a very different scale story, and the analysis report for Perimeter Medical Imaging AI shows where Perimeter Medical Imaging AI’s risk and upside may be separating.

Seeking Alternatives Before Momentum Flies

Fresh ideas move first and slow portfolios get caught watching. Scan for breakouts and dropping risks while it still matters, before the crowd, and consider acting early if it aligns with your strategy.

• Spot potential momentum leaders early by reviewing the curated 5 high quality undervalued stocks that could be setting up before most investors notice.
• Target resilient payers while yields still hold by checking the hand picked 1 dividend fortresses that may help support income streams.
• Position for the next wave of automation by tracking the focused 93 robotics and automation stocks that could gain attention as adoption builds.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com